Method and device for nucleic acid based diagnostic approaches including the determination of a deviant condition, especially a health condition and/or a pathogenic condition of a sample

US10910088B2 · kind B2 · utility

Assignees

• Fraunhofer-Gesellschaft zur förderung der angewandten Forschung e.V. · DE
• UNIVERSITAT STUTTGART · DE
• Medizinische Universität Wien · AT
• UNIVERSITÄT WIEN · AT

Inventors

• Kai Sohn · Tegernsee, DE
• Silke Grumaz · Waiblingen, DE
• Philip Stevens · Stuttgart, DE
• Arndt Von Haeseler · Scharndorf, AT

Key dates

• Filing date: Sep 8, 2016
• Grant date: Feb 2, 2021
• Expiry date: Mar 3, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/158
• WIPO field: Computer technology
• WIPO sector: Electrical engineering

Abstract

The present invention relates to a method and a device for a nucleic acid based diagnostic approach including the determination of a deviant condition of a sample, wherein the deviant condition is preferably a health condition and/or a pathogenic condition.